MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PBYI has $202,862K in assets. $87,594K in debts. $53,525K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
173.56%
Quick Ratio
162.10%
Cash Ratio
64.70%
Debt to Asset Ratio
43.18%
Assets Breakdown
    • Cash and cash equivalents
    • Intangible assets, net
    • Marketable securities
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses, current
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
53,525 54,662
Marketable securities
40,863 41,362
Accounts receivable, net of allowance for credit loss of 0 and 362
33,565 25,910
Inventory
9,476 8,591
Prepaid expenses, current
3,830 3,889
Restricted cash, current
2,091 2,091
Other assets, current
230 73
Total current assets
143,580 136,578
Lease right-of-use assets, net
6,147 2,828
Property, plant and equipment, gross
6,894 -
Less accumulated depreciation
6,589 -
Property and equipment, net
305 388
Intangible assets, net
43,827 46,262
Restricted cash, long-term
0 0
Deferred tax assets
7,075 7,075
Prepaid expenses and other, long-term
1,928 1,785
Total assets
202,862 194,916
Accounts payable
6,386 5,424
Accrued expenses, current
37,116 31,797
Lease liabilities, current
2,470 4,364
Post-marketing commitment liability
2,858 3,294
Current portion of long-term debt
33,716 33,997
Other liabilities, current
182 223
Total current liabilities
82,728 79,099
Lease liabilities, long-term
4,866 0
Post-marketing commitment liability, long-term
0 230
Total long-term debt, net
0 10,869
Other liabilities, long-term
0 0
Total liabilities
87,594 90,198
Common stock - .0001 par value per share 100,000,000 shares authorized 50,384,274 shares issued and outstanding at september 30, 2025 and 49,105,834 issued and outstanding at december 31, 2024
5 5
Additional paid-in capital
1,412,457 1,410,784
Accumulated other comprehensive income
19 -14
Accumulated deficit
-1,297,213 -1,306,057
Total stockholders equity
115,268 104,718
Total liabilities and stockholders equity
202,862 194,916
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property, plant andequipment, gross$6,894K Other assets, current$230K Restricted cash, current$2,091K Prepaid expenses,current$3,830K Inventory$9,476K Accounts receivable, netof allowance for...$33,565K Marketable securities$40,863K Cash and cashequivalents$53,525K Prepaid expenses andother, long-term$1,928K Deferred tax assets$7,075K Intangible assets, net$43,827K Property and equipment,net$305K Lease right-of-useassets, net$6,147K Total current assets$143,580K Less accumulateddepreciation$6,589K Total assets$202,862K Total liabilities andstockholders equity$202,862K Total stockholdersequity$115,268K Total liabilities$87,594K Accumulated deficit-$1,297,213K Accumulated othercomprehensive income$19K Additional paid-in capital$1,412,457K Lease liabilities,long-term$4,866K Total currentliabilities$82,728K Common stock - .0001 parvalue per share...$5K Other liabilities,current$182K Current portion oflong-term debt$33,716K Post-marketing commitmentliability$2,858K Lease liabilities,current$2,470K Accrued expenses,current$37,116K Accounts payable$6,386K

PUMA BIOTECHNOLOGY, INC. (PBYI)

PUMA BIOTECHNOLOGY, INC. (PBYI)